{
  "disease_name": "Infantile neuroaxonal dystrophy",
  "orpha_code": "35069",
  "drugs": [
    {
      "name": "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene",
      "substance_url": "/en/drug/substance/661197?name=35069&mode=orpha&region=&status=all",
      "substance_id": "661197",
      "regulatory_url": "/en/drug/regulatory/661292?name=35069&mode=orpha&region=",
      "regulatory_id": "661292",
      "orpha_substance_code": "ORPHA:35069",
      "details": [
        "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene(Medicinal product                        - 13/10/2023)Disease(s) concernedORPHA:35069 Infantile neuroaxonal dystrophy",
        "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene(Medicinal product                        - 13/10/2023)",
        "(Medicinal product                        - 13/10/2023)",
        "Disease(s) concernedORPHA:35069 Infantile neuroaxonal dystrophy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661197?name=35069&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/35069",
          "text": "ORPHA:35069 Infantile neuroaxonal dystrophy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661292?name=35069&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester",
      "substance_url": "/en/drug/substance/559146?name=35069&mode=orpha&region=&status=all",
      "substance_id": "559146",
      "regulatory_url": "/en/drug/regulatory/559147?name=35069&mode=orpha&region=",
      "regulatory_id": "559147",
      "orpha_substance_code": "ORPHA:35069",
      "details": [
        "9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester(Medicinal product                        - 26/02/2019)Disease(s) concernedORPHA:35069 Infantile neuroaxonal dystrophy",
        "9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester(Medicinal product                        - 26/02/2019)",
        "(Medicinal product                        - 26/02/2019)",
        "Disease(s) concernedORPHA:35069 Infantile neuroaxonal dystrophy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/559146?name=35069&mode=orpha&region=&status=all",
          "text": "9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/35069",
          "text": "ORPHA:35069 Infantile neuroaxonal dystrophy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/559147?name=35069&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Deferiprone",
      "substance_url": "/en/drug/substance/42568?name=35069&mode=orpha&region=&status=all",
      "substance_id": "42568",
      "regulatory_url": "/en/drug/regulatory/520903?name=35069&mode=orpha&region=",
      "regulatory_id": "520903",
      "orpha_substance_code": "ORPHA:385",
      "details": [
        "Deferiprone(Medicinal product                        - 27/06/2018)Disease(s) concernedORPHA:385 Neurodegeneration with brain iron accumulation",
        "Deferiprone(Medicinal product                        - 27/06/2018)",
        "(Medicinal product                        - 27/06/2018)",
        "Disease(s) concernedORPHA:385 Neurodegeneration with brain iron accumulation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/42568?name=35069&mode=orpha&region=&status=all",
          "text": "Deferiprone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/385",
          "text": "ORPHA:385 Neurodegeneration with brain iron accumulation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/520903?name=35069&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene",
      "substance_url": "/en/drug/substance/661197?name=35069&mode=orpha&region=&status=all",
      "substance_id": "661197",
      "regulatory_url": "/en/drug/regulatory/691490?name=35069&mode=orpha&region=",
      "regulatory_id": "691490",
      "orpha_substance_code": "ORPHA:329303",
      "details": [
        "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene(Medicinal product                        - 29/11/2024)Disease(s) concernedORPHA:329303 PLA2G6-associated neurodegeneration",
        "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene(Medicinal product                        - 29/11/2024)",
        "(Medicinal product                        - 29/11/2024)",
        "Disease(s) concernedORPHA:329303 PLA2G6-associated neurodegeneration",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661197?name=35069&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/329303",
          "text": "ORPHA:329303 PLA2G6-associated neurodegeneration",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/691490?name=35069&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene",
      "substance_url": "/en/drug/substance/661197?name=35069&mode=orpha&region=&status=all",
      "substance_id": "661197",
      "regulatory_url": "/en/drug/regulatory/661645?name=35069&mode=orpha&region=",
      "regulatory_id": "661645",
      "orpha_substance_code": "ORPHA:329303",
      "details": [
        "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene(Medicinal product                        - 15/09/2023)Disease(s) concernedORPHA:329303 PLA2G6-associated neurodegeneration",
        "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene(Medicinal product                        - 15/09/2023)",
        "(Medicinal product                        - 15/09/2023)",
        "Disease(s) concernedORPHA:329303 PLA2G6-associated neurodegeneration",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661197?name=35069&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/329303",
          "text": "ORPHA:329303 PLA2G6-associated neurodegeneration",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661645?name=35069&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:04:22.094508",
  "run_number": 1,
  "total_drugs_found": 5,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Infantile+neuroaxonal+dystrophy&orphaCode=35069&name=35069&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Infantile neuroaxonal dystrophy",
    "orphaCode": "35069",
    "name": "35069",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}